Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Endocrinology
•
Bone and Calcium Disorders
How do you monitor patients with Paget’s disease with normal serum alkaline phosphatase?
Related Questions
Should patients who develop primary hyperparathyroidism after 5 years of Prolia treatment for osteoporosis be referred for parathyroidectomy?
Would you consider PTH analogue in a patient with mildly elevated PTH?
How do you manage osteoporosis in patients with anorexia nervosa (who often are young women < 40)?
How should patients time the ingestion of their alendronate and levothyroxine given issues with food/drug interactions?
Do you recommend osteoporosis medication in postmenopausal females on anastrozole with very low Vitamin D (4.5)?
How do you distinguish between primary and tertiary hyperparathyroidism in a patient with ESRD?
What range of musculoskeletal complaints have you seen with romosozumab use?
Is there any evidence regarding bone density gains/fracture reduction in the setting of treatment with romosozumab after a two year course of teriparatide?
Do you recommend a particular antiresorptive/anabolic agent for patients who are at high risk for fractures but have high risk of osteonecrosis of the jaw?
Is there any data or advice on using teriparatide after romosozumab for treatment of postmenopausal osteoporosis?
